SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950123-97-006967
Filing Date
1997-08-15
Accepted
1997-08-15 00:00:00
Documents
4
Group Members
UBS (LUX) EQUITY INVEST - BIOTECHUBS ASSET MANAGEMENT NEW YORK INC
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 VIROPHARMA, INC. SC 13D 15358
2 LIST OF DIRECTORS AND EXECUTIVE OFFICERS EX-99.A 6430
3 LIST OF DIRECTORS AND EXECUTIVE OFFICERS EX-99.B 1348
4 SSCHEDULE OF TRANSACTIONS EX-99.C 856
  Complete submission text file 0000950123-97-006967.txt   26243
Mailing Address
Business Address 1345 AVENUE OF THE AMERICAS WEST 54TH & 55TH ST - 49TH FL NEW YORK NY 10105 2126497100
UBS ASSET MANAGEMENT NEW YORK INC (Filed by) CIK: 0000881153 (see all company filings)

 

Mailing Address 76 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 76 GREAT VALLEY PARKWAY PO BOX 5000 MALVERN PA 19355 6106510200
VIROPHARMA INC (Subject) CIK: 0000946840 (see all company filings)

IRS No.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-48239 | Film No.: 97664311
SIC: 2834 Pharmaceutical Preparations